Microvesicle-associated AAV vector as a novel gene delivery system.

Area of Science:

• Biotechnology
• Gene Therapy
• Molecular Biology

Background:

• Adeno-associated virus (AAV) vectors are efficient for gene delivery but face limitations like off-target delivery and low transduction rates after intravenous administration.
• Existing AAV gene transfer methods struggle with efficiency and specificity, hindering their therapeutic potential.

Purpose of the Study:

• To investigate the potential of AAV vectors associated with microvesicles/exosomes, termed vexosomes, for improved gene delivery.
• To characterize vexosomes and evaluate their transduction efficiency, stability, and targeted delivery capabilities.

Main Methods:

• Electron microscopy was used to visualize AAV capsids within and on the surface of microvesicles (vexosomes).
• Transduction efficiency of vexosomes was compared to conventionally purified AAV vectors in cultured cells.
• Neutralizing anti-AAV antibody resistance and magnetic targeting of vexosomes were assessed.

Main Results:

• A fraction of AAV vectors were identified as vexosomes during production, associated with microvesicles.
• Vexosomes demonstrated superior transduction efficiency compared to conventionally purified AAV vectors in vitro.
• Purified vexosomes exhibited enhanced resistance to neutralizing antibodies and showed potential for magnetic targeting.

Conclusions:

• Vexosomes represent a novel AAV vector entity with improved gene delivery characteristics.
• This vector-exosome association offers a promising strategy to overcome current limitations in AAV-mediated gene therapy.
• Vexosomes may enhance the efficacy and specificity of gene transfer applications.